Comparative Analysis of Clinicopathological Characteristics, Survival Features, and Protein Expression Between Basaloid and Squamous Cell Carcinoma of the Esophagus

References

• Gupta B, Kumar N. Worldwide incidence, mortality and time trends for cancer of the oesophagus. Eur J Cancer Prev. 2017;26(2):107–118. doi:10.1097/CEJ.0000000000000249
   PubMed Web of Science ®Google Scholar
• Pennathur A, Gibson MK, Jobe BA, et al. Oesophageal carcinoma. Lancet. 2013;381(9864):400–412. doi:10.1016/S0140-6736(12)60643-6
   PubMed Web of Science ®Google Scholar
• Napier KJ, Scheerer M, Misra S. Esophageal cancer: a Review of epidemiology, pathogenesis, staging workup and treatment modalities. World J Gastrointest Oncol. 2014;6(5):112–120. doi:10.4251/wjgo.v6.i5.112
   PubMed Web of Science ®Google Scholar
• Huang Z, Liang Y, Wu X. [Basaloid squamous carcinoma of the oesophagus: a distinctive clinico-pathological entity]. Zhonghua Bing Li Xue Za Zhi. 1995;24(2):90–92. Chinese.
   PubMedGoogle Scholar
• Sarbia M, Verreet P, Bittinger F, et al. Basaloid squamous cell carcinoma of the esophagus: diagnosis and prognosis. Cancer. 1997;79(10):1871–1878. doi:10.1002/(SICI)1097-0142(19970515)79:10<1871::AID-CNCR5>3.0.CO;2-J
   PubMed Web of Science ®Google Scholar
• Morice WG, Ferreiro JA. Distinction of basaloid squamous cell carcinoma from adenoid cystic and small cell undifferentiated carcinoma by immunohistochemistry. Hum Pathol. 1998;29(6):609–612. doi:10.1016/S0046-8177(98)80011-7
   PubMed Web of Science ®Google Scholar
• Sato-Kuwabara Y, Fregnani JHTG, Jampietro J, et al. Comparative analysis of basaloid and conventional squamous cell carcinomas of the esophagus: prognostic relevance of clinicopathological features and protein expression. Tumour Biol. 2016;37(5):6691–6699. doi:10.1007/s13277-015-4551-3
   PubMedGoogle Scholar
• Lam KY, Law S, Luk JM, et al. Oesophageal basaloid squamous cell carcinoma: a unique clinicopathological entity with telomerase activity as a prognostic indicator. J Pathol. 2001;195(4):435–442. doi:10.1002/path.984
   PubMed Web of Science ®Google Scholar
• Cho C, et al. Basaloid squamous carcinoma of the oesophagus: a distinct neoplasm with multipotential differentiation. Histopathology. 2000;36(4):331–340. doi:10.1046/j.1365-2559.2000.00851.x
   PubMed Web of Science ®Google Scholar
• Li TJ, Zhang Y-X, Wen J, et al. Basaloid squamous cell carcinoma of the esophagus with or without adenoid cystic features. Arch Pathol Lab Med. 2004;128(10):1124–1130. doi:10.5858/2004-128-1124-BSCCOT
   PubMed Web of Science ®Google Scholar
• Baba Y, Ishimoto T, Harada K, et al. Molecular characteristics of basaloid squamous cell carcinoma of the esophagus: analysis of KRAS, BRAF, and PIK3CA mutations and LINE-1 methylation. Ann Surg Oncol. 2015;22(11):3659–3665. doi:10.1245/s10434-015-4445-z
   PubMed Web of Science ®Google Scholar
• Shibata Y, Baba E, Ariyama H, et al. Metastatic basaloid-squamous cell carcinoma of the esophagus treated by 5-fluorouracil and cisplatin. World J Gastroenterol. 2007;13(26):3634–3637. doi:10.3748/wjg.v13.i26.3634
   PubMed Web of Science ®Google Scholar
• Zhang B-H, Cheng G-Y, Xue Q, et al. Clinical outcomes of basaloid squamous cell carcinoma of the esophagus: a retrospective analysis of 142 cases. Asian Pac J Cancer Prev. 2013;14(3):1889–1894. doi:10.7314/APJCP.2013.14.3.1889
   PubMedGoogle Scholar
• Tripathi M, Swanson PE. Rare tumors of esophageal squamous mucosa. Ann N Y Acad Sci. 2016;1381(1):122–132. doi:10.1111/nyas.13108
   PubMed Web of Science ®Google Scholar
• Chen S-B, Weng H-R, Wang G, et al. Basaloid squamous cell carcinoma of the esophagus. J Cancer Res Clin Oncol. 2012;138(7):1165–1171. doi:10.1007/s00432-012-1180-8
   PubMed Web of Science ®Google Scholar
• Deng H-Y, Chen Z-H, Wang Z-Q, et al. High expression of Ki-67 is an independent favorable prognostic factor for esophageal small cell carcinoma. Oncotarget. 2017;8(33):55298–55307. doi:10.18632/oncotarget.19426
   PubMedGoogle Scholar
• Wang H, Zhou Y, Qian L, et al. Prognostic value of SOX2, Cyclin D1, P53, and ki-67 in patients with esophageal squamous cell carcinoma</em>. Onco Targets Ther. 2018;11:5171–5181. doi:10.2147/OTT.S160066
   PubMed Web of Science ®Google Scholar
• Yu W, Yang X, Chu L, et al. Prognostic value of EGFR family expression in lymph node-negative esophageal squamous cell carcinoma patients. Pathol Res Pract. 2018;214(7):1017–1023. doi:10.1016/j.prp.2018.04.017
   PubMed Web of Science ®Google Scholar
• Imamhasan A, Mitomi H, Saito T, et al. Immunohistochemical and oncogenetic analyses of the esophageal basaloid squamous cell carcinoma in comparison with conventional squamous cell carcinomas. Hum Pathol. 2012;43(11):2012–2023. doi:10.1016/j.humpath.2012.02.010
   PubMed Web of Science ®Google Scholar
• Akagi I, Miyashita M, Makino H, et al. Basaloid squamous cell carcinoma of the esophagus: report of two cases. J Nippon Med Sch. 2008;75(6):354–360. doi:10.1272/jnms.75.354
   PubMedGoogle Scholar
• Nishimura W, Naomoto Y, Hamaya K, et al. Basaloid-squamous cell carcinoma of the esophagus: diagnosis based on immunohistochemical analysis. J Gastroenterol Hepatol. 2001;16(5):586–590. doi:10.1046/j.1440-1746.2001.02424.x
   PubMed Web of Science ®Google Scholar
• Oguma J, Ozawa S, Kazuno A, et al. Clinicopahological features of superficial basaloid squamous cell carcinoma of the esophagus. Dis Esophagus. 2017;30(12):1–5. doi:10.1093/dote/dox076
   PubMed Web of Science ®Google Scholar
• Tada T, Honma R, Imai J-I, et al. A novel gene expression scoring system for accurate diagnosis of basaloid squamous cell carcinoma of the esophagus. Int J Oncol. 2017;51(3):877–886. doi:10.3892/ijo.2017.4075
   PubMed Web of Science ®Google Scholar
• Zhang XH, Sun GQ, Zhou XJ, Guo HF, Zhang TH. Basaloid squamous carcinoma of esophagus: aclinicopathological, immunohistochemical and electron microscopic study of sixteen cases. World J Gastroenterol. 1998;4(5):397–403. doi:10.3748/wjg.v4.i5.397
   PubMed Web of Science ®Google Scholar
• Sarbia M, Loberg C, Wolter M, et al. Expression of Bcl-2 and amplification of c-myc are frequent in basaloid squamous cell carcinomas of the esophagus. Am J Pathol. 1999;155(4):1027–1032. doi:10.1016/S0002-9440(10)65203-0
   PubMed Web of Science ®Google Scholar
• Bellizzi AM, Woodford RL, Moskaluk CA, et al. Basaloid squamous cell carcinoma of the esophagus: assessment for high-risk human papillomavirus and related molecular markers. Am J Surg Pathol. 2009;33(11):1608–1614. doi:10.1097/PAS.0b013e3181b46fd4
   PubMed Web of Science ®Google Scholar
• Ohashi K, Horiguchi S, Moriyama S, et al. Superficial basaloid squamous carcinoma of the esophagus. A clinicopathological and immunohistochemical study of 12 cases. Pathol Res Pract. 2003;199(11):713–721. doi:10.1078/0344-0338-00487
   PubMed Web of Science ®Google Scholar
• Salami A, Abbas AE, Petrov R, et al. Comparative analysis of clinical, treatment, and survival characteristics of basaloid and squamous cell carcinoma of the esophagus. J Am Coll Surg. 2018;226(6):1086–1092. doi:10.1016/j.jamcollsurg.2017.10.019
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Nakanishi Y, Taniguchi H, et al. Histological diversity in basaloid squamous cell carcinoma of the esophagus. Dis Esophagus. 2009;22(3):231–238. doi:10.1111/j.1442-2050.2008.00864.x
   PubMed Web of Science ®Google Scholar
• Wang L, Yang HY, Zheng YQ. Personalized medicine of esophageal cancer. J Cancer Res Ther. 2012;8(3):343–347. doi:10.4103/0973-1482.103510
   PubMed Web of Science ®Google Scholar
• Kawamura T, Goseki N, Koike M, et al. Acceleration of proliferative activity of esophageal squamous cell carcinoma with invasion beyond the mucosa: immunohistochemical analysis of Ki-67 and p53 antigen in relation to histopathologic findings. Cancer. 1996;77(5):843–849. doi:10.1002/(SICI)1097-0142(19960301)77:5<843::AID-CNCR6>3.0.CO;2-F
   PubMed Web of Science ®Google Scholar
• Hara T, Kijima H, Yamamoto S, et al. Ubiquitous p63 expression in human esophageal squamous cell carcinoma. Int J Mol Med. 2004;14(2):169–173.
   PubMed Web of Science ®Google Scholar
• Shimaya K, Shiozaki H, Inoue M, et al. Significance of p53 expression as a prognostic factor in oesophageal squamous cell carcinoma. Virchows Arch a Pathol Anat Histopathol. 1993;422(4):271–276. doi:10.1007/BF01608335
   PubMedGoogle Scholar
• Glickman JN, Yang A, Shahsafaei A, et al. Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders. Hum Pathol. 2001;32(11):1157–1165. doi:10.1053/hupa.2001.28951
   PubMed Web of Science ®Google Scholar
• Hu H, Xia S-H, Li A-D, et al. Elevated expression of p63 protein in human esophageal squamous cell carcinomas. Int J Cancer. 2002;102(6):580–583. doi:10.1002/ijc.10739
   PubMed Web of Science ®Google Scholar
• Massion PP, Taflan PM, Jamshedur Rahman SM, et al. Significance of p63 amplification and overexpression in lung cancer development and prognosis. Cancer Res. 2003;63(21):7113–7121.
   PubMed Web of Science ®Google Scholar
• Massion PP, Taflan PM, Rahman SMJ, et al. Role of p63 amplification and overexpression in lung cancer development. Chest. 2004;125(5):102S. doi:10.1378/chest.125.5_suppl.102S-a
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Noguchi T, Takeno S, et al. Reduced expression of p63 has prognostic implications for patients with esophageal squamous cell carcinoma. Oncol Rep. 2006;15(2):323–328.
   PubMed Web of Science ®Google Scholar
• Yu WW, Guo Y-M, Zhu M, et al. Clinicopathological and prognostic significance of EGFR over-expression in esophageal squamous cell carcinoma: a meta-analysis. Hepatogastroenterology. 2011;58(106):426–431.
   PubMedGoogle Scholar